Cohen SP, Vase L, Hooten WM. Chronic pain: an update on burden, best practices, and new advances. Lancet. 2021;397(10289):2082–97.

PubMed  Google Scholar 

Volkow ND, Blanco C. The changing opioid crisis: development, challenges and opportunities. Mol Psychiatry. 2021;26(1):218–33.

PubMed  Google Scholar 

Duarte DF. Opium and opioids: a brief history. Rev Bras Anestesiol. 2005;55(1):135–46.

PubMed  Google Scholar 

Santoro D, Bellinghieri G, Savica V. Development of the concept of pain in history. J Nephrol. 2011;24(Suppl 17):S133–6.

PubMed  Google Scholar 

Abdel Shaheed C, Maher CG, Williams KA, Day R, McLachlan AJ. Efficacy, tolerability, and dose-dependent effects of opioid analgesics for low back pain: a systematic review and meta-analysis. JAMA Intern Med. 2016;176(7):958–68.

PubMed  Google Scholar 

de Leon-Casasola OA. Opioids for chronic pain: new evidence, new strategies, safe prescribing. Am J Med. 2013;126(3 Suppl 1):S3-11.

PubMed  Google Scholar 

Kissin I. The development of new analgesics over the past 50 years: a lack of real breakthrough drugs. Anesth Analg. 2010;110(3):780–9.

CAS  PubMed  Google Scholar 

WHO Expert Committee. The selection and use of essential medicines: report of the WHO Expert Committee, 2017 (including the 20th WHO Model List of Essential Medicines and the 6th WHO Model List of essential Medicines for Children). WHO technical report series ; no 1006. Geneva: World Health Organization; 2017. p. 604.

Shipton EA, Shipton EE, Shipton AJ. A review of the opioid epidemic: what do we do about it? Pain Ther. 2018;7(1):23–36.

PubMed  PubMed Central  Google Scholar 

Manchikanti L, Helm S 2nd, Fellows B, Janata JW, Pampati V, Grider JS, et al. Opioid epidemic in the United States. Pain Physician. 2012;15(3 Suppl):ES9-38.

PubMed  Google Scholar 

Webster L, Schmidt WK. Dilemma of addiction and respiratory depression in the treatment of pain: a prototypical endomorphin as a new approach. Pain Med. 2019;21(5):992–1004.

Wang Y, Zhuang Y, DiBerto JF, Zhou XE, Schmitz GP, Yuan Q, et al. Structures of the entire human opioid receptor family. Cell. 2023;186(2):413-271e7.

CAS  PubMed  Google Scholar 

Matthes HW, Maldonado R, Simonin F, Valverde O, Slowe S, Kitchen I, et al. Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene. Nature. 1996;383(6603):819–23.

CAS  PubMed  Google Scholar 

Hsia JA, Moss J, Hewlett EL, Vaughan M. ADP-ribosylation of adenylate cyclase by pertussis toxin. Effects on inhibitory agonist binding. J Biol Chem. 1984;259(2):1086–90.

CAS  PubMed  Google Scholar 

Taussig R, Iniguez-Lluhi JA, Gilman AG. Inhibition of adenylyl cyclase by Gi alpha. Science. 1993;261(5118):218–21.

CAS  PubMed  Google Scholar 

Ippolito DL, Temkin PA, Rogalski SL, Chavkin C. N-terminal tyrosine residues within the potassium channel Kir3 modulate GTPase activity of Galphai. J Biol Chem. 2002;277(36):32692–6.

CAS  PubMed  Google Scholar 

Sadja R, Alagem N, Reuveny E. Gating of GIRK channels. Neuron. 2003;39(1):9–12.

CAS  PubMed  Google Scholar 

Díaz A, Flórez J, Pazos A, Hurlé MA. Opioid tolerance and supersensitivity induce regional changes in the autoradiographic density of dihydropyridine-sensitive calcium channels in the rat central nervous system. Pain. 2000;86(3):227–35.

PubMed  Google Scholar 

Diaz A, Ruiz F, Florez J, Pazos A, Hurle MA. Regulation of dihydropyridine-sensitive Ca++ channels during opioid tolerance and supersensitivity in rats. J Pharmacol Exp Ther. 1995;274(3):1538–44.

CAS  PubMed  Google Scholar 

Wickman K, Clapham DE. Ion channel regulation by G proteins. Physiol Rev. 1995;75(4):865–85.

CAS  PubMed  Google Scholar 

Dang VC, Christie MJ. Mechanisms of rapid opioid receptor desensitization, resensitization and tolerance in brain neurons. Br J Pharmacol. 2012;165(6):1704–16.

CAS  PubMed  PubMed Central  Google Scholar 

Groer CE, Schmid CL, Jaeger AM, Bohn LM. Agonist-directed interactions with specific beta-arrestins determine mu-opioid receptor trafficking, ubiquitination, and dephosphorylation. J Biol Chem. 2011;286(36):31731–41.

CAS  PubMed  PubMed Central  Google Scholar 

Melief EJ, Miyatake M, Bruchas MR, Chavkin C. Ligand-directed c-Jun N-terminal kinase activation disrupts opioid receptor signaling. Proc Natl Acad Sci U S A. 2010;107(25):11608–13.

CAS  PubMed  PubMed Central  Google Scholar 

Whistler JL, Chuang H-h, Chu P, Jan LY, von Zastrow M. Functional dissociation of μ-opioid receptor signaling and endocytosis. Neuron. 1999;23(4):737–46.

CAS  PubMed  Google Scholar 

Gondin AB, Halls ML, Canals M, Briddon SJ. GRK mediates mu-opioid receptor plasma membrane reorganization. Front Mol Neurosci. 2019;12:104.

CAS  PubMed  PubMed Central  Google Scholar 

Raffa RB, Martinez RP, Connelly CD. G-protein antisense oligodeoxyribonucleotides and μ-opioid supraspinal antinociception. Eur J Pharmacol. 1994;258(1–2):R5–7.

CAS  PubMed  Google Scholar 

Bohn LM, Lefkowitz RJ, Gainetdinov RR, Peppel K, Caron MG, Lin FT. Enhanced morphine analgesia in mice lacking beta-arrestin 2. Science. 1999;286(5449):2495–8.

CAS  PubMed  Google Scholar 

Raehal KM, Walker JK, Bohn LM. Morphine side effects in β-arrestin 2 knockout mice. J Pharmacol Exp Ther. 2005;314(3):1195–201.

CAS  PubMed  Google Scholar 

Bohn LM, Gainetdinov RR, Lin FT, Lefkowitz RJ, Caron MG. Mu-opioid receptor desensitization by beta-arrestin-2 determines morphine tolerance but not dependence. Nature. 2000;408(6813):720–3.

CAS  PubMed  Google Scholar 

Gaveriaux-Ruff C, Kieffer BL. Opioid receptor genes inactivated in mice: the highlights. Neuropeptides. 2002;36(2–3):62–71.

CAS  PubMed  Google Scholar 

Yang CH, Huang HW, Chen KH, Chen YS, Sheen-Chen SM, Lin CR. Antinociceptive potentiation and attenuation of tolerance by intrathecal beta-arrestin 2 small interfering RNA in rats. Br J Anaesth. 2011;107(5):774–81.

CAS  PubMed  Google Scholar 

Kliewer A, Schmiedel F, Sianati S, Bailey A, Bateman JT, Levitt ES, et al. Phosphorylation-deficient G-protein-biased mu-opioid receptors improve analgesia and diminish tolerance but worsen opioid side effects. Nat Commun. 2019;10(1):367.

CAS  PubMed  PubMed Central  Google Scholar 

Bull FA, Baptista-Hon DT, Sneddon C, Wright L, Walwyn W, Hales TG. Src kinase inhibition attenuates morphine tolerance without affecting reinforcement or psychomotor stimulation. Anesthesiology. 2017;127(5):878–89.

CAS  PubMed  Google Scholar 

Kliewer A, Gillis A, Hill R, Schmiedel F, Bailey C, Kelly E, et al. Morphine-induced respiratory depression is independent of beta-arrestin2 signalling. Br J Pharmacol. 2020;177(13):2923–31.

CAS  PubMed  PubMed Central  Google Scholar 

Chen YJ, Oldfield S, Butcher AJ, Tobin AB, Saxena K, Gurevich VV, et al. Identification of phosphorylation sites in the COOH-terminal tail of the mu-opioid receptor. J Neurochem. 2013;124(2):189–99.

CAS  PubMed  Google Scholar 

Miess E, Gondin AB, Yousuf A, Steinborn R, Mosslein N, Yang Y, et al. Multisite phosphorylation is required for sustained interaction with GRKs and arrestins during rapid mu-opioid receptor desensitization. Sci Signal. 2018;11(539):eaas9609.

Bachmutsky I, Wei XP, Durand A, Yackle K. B-arrestin 2 germline knockout does not attenuate opioid respiratory depression. Elife. 2021;18:10.

Google Scholar 

Gregory KJ. Commentary on “Morphine-induced respiratory depression is independent of beta-arrestin2 signalling.” Br J Pharmacol. 2020;177(13):2904–5.

CAS  PubMed  PubMed Central  Google Scholar 

Lam H, Maga M, Pradhan A, Evans CJ, Maidment NT, Hales TG, et al. Analgesic tone conferred by constitutively active mu opioid receptors in mice lacking beta-arrestin 2. Mol Pain. 2011;12(7):24.

Google Scholar 

Stone LS, Molliver DC. In search of analgesia: emerging roles of GPCRs in pain. Mol Interv. 2009;9(5):234–51.

CAS  PubMed  PubMed Central  Google Scholar 

Rajagopal S, Rajagopal K, Lefkowitz RJ. Teaching old receptors new tricks: biasing seven-transmembrane receptors. Nat Rev Drug Discov. 2010;9(5):373–86.

CAS  PubMed  PubMed Central  Google Scholar 

Audet M, Bouvier M. Restructuring G-protein- coupled receptor activation. Cell. 2012;151(1):14–23.